Introduction

P
hyllodes tumor is a rare fibroepithelial neoplasm with malignant phyllodes having high risk of recurrence and metastasis. It accounts for 0.3%-0.5% of female breast tumors. [1] In 1838, Johannes Muller coined the term cystosarcoma phyllodes while, later in 1981, the term phyllodes tumor was adopted by the WHO. [2] At present, it has been classified as benign, borderline, and malignant according to several characteristics such as margins, stromal overgrowth, atypia, and mitosis. These tumors originate from periductal stroma and comprise stromal and epithelial elements. [3] The epithelial component is benign while the hyperproliferative stromal component is malignant. Diagnosis of phyllodes tumor on fine-needle aspiration cytology is difficult. Thus, preoperative imaging and biopsy remain the preliminary diagnostic tool for phyllodes tumor. Diagnosis remains challenging, especially in distinction of phyllodes from other fibroepithelial lesions, such as giant fibroadenoma both on imaging and in trucut. This uncertainty in diagnosis makes it difficult to further streamline the treatment. We present here a series of 20 patients comparing their histopathological diagnosis on resected specimens with their respective trucut biopsies.
Materials and Methods
Around 3200 histopathology specimens of the breast (trucut and resected specimens) were received 6. On trucut biopsies of the patients, the following four stromal features were assessed: stromal cellularity, stromal atypia, mitosis, and relative proportion of the stroma to the epithelium. On the basis of these features, 14 cases (70%) were diagnosed to be benign phyllodes while 6 (30%) had malignant features [ Table 3 ] 7. Histomorphologic features of final surgical specimen (lumpectomy/mastectomy) were studied on the basis of the WHO 2012 grading system for phyllodes tumor. Seven (35%) cases were found to be benign [ Figure 2a and b], four (20%) were found to be borderline [ Figure 2c and d], while nine (45%) were found to be malignant [ Figure 3a , b and Table 4 ] 8. Two cases had associated heterologous elements showing chondrosarcomatous [ Figure 3c ] and leiomyosarcomatous [ Figure 3d ] differentiation, while one showed only chondrosarcomatous elements 9. Lymph nodes isolated showed reactive changes only with the absence of any tumor 10. Three cases with diagnosis of benign phyllodes on trucut were finally diagnosed as malignant phyllodes on final histopathology report 11. Four cases diagnosed as benign on trucut were diagnosed as borderline phyllodes eventually [ Table 5] 12. Sensitivity of trucut in diagnosing benign phyllodes was 100%, and specificity was 46.15%. Positive predictive value was 50% and negative predictive value was 100% 13. Sensitivity of trucut in diagnosing malignant phyllodes was 66.6% and specificity was 100%.
Positive predictive value was 100% while negative predictive value was 78. 5%.
Discussion
Phyllodes tumors are rare fibroepithelial lesions. They occur in women aged 35-55 years of age [4] and usually present as a painless lump with slow progression. It has an equal propensity to occur in either of the breast with a rare bilateral presentation [5] and is more commonly found in the upper outer quadrant. In our study, the mean age was found to be 37.9 years while the youngest patient was 14 years. The most common presentation was painless lump in the breast; however, three patients had associated skin involvement and discharge from the lump. The left breast (65%) was more affected than the right with no patient having bilateral involvement in our series. In the present series, all the quadrants were involved in 55% cases with the upper outer quadrant being involved in 35%.
The most favored theory on pathogenesis of phyllodes is epithelial-stromal interactions. Frequent MDM12 somatic mutations are identified in fibroadenoma and phyllodes, suggesting a common origin for these two. [6, 7] Size of phyllodes tumor varies from 1 cm to 40 cm. [8] About 20% tumors grow larger than 10 cm, when they are named as giant phyllodes. In the present study, the tumor size varied from 5 cm × 4 cm to 30 cm × 25 cm with 65% of cases presenting as giant phyllodes. Duration of presenting complaints in our study ranged from 6 months to 6 years.
Palpable axillary lymphadenopathy has been reported in up to 20% with 5% presenting with positive nodes. [9] Patients with lymph node metastasis have a poor prognosis. The mode of metastasis is commonly hematogenous and rarely lymph nodes are involved. Common sites of metastasis include lung, soft tissue, and bone. In the present series, lymph nodes isolated from patients showed reactive changes, and no lymphatic metastasis was identified.
On gross, phyllodes appear as solid, lobulated, and gray-white in color with hemorrhagic, necrotic, and cystic areas within. Phyllodes tumors are biphasic with both mesenchymal and epithelial components. A characteristic leaf-like architecture is present with epithelial components forming benign ducts while the hypercellular stroma forming the malignant counterpart. These fibroblasts can also differentiate into heterologous elements such as fat, cartilage, smooth muscle, and striated muscle. The presence of these components indicates poor prognosis. [10] In our study, two cases showed heterologous differentiation Figure  3c ] and leiomyosarcomatous [ Figure 3d ] elements.
Mammography, ultrasonography, and magnetic resonance imaging (MRI) are routine imaging diagnostic modalities. However, none of them are characteristic of phyllodes and features overlap with fibroadenoma. [10, 11] Accurate cytological diagnosis of phyllodes by fine-needle aspiration cytology (FNAC) is also difficult, especially in differentiating benign phyllodes from fibroadenoma. The presence of hypercellular stromal fragments and stromal elements being more numerous than epithelial ones is suggestive of phyllodes tumor on cytology. [5] Radiological investigations including mammogram, ultrasound, and FNAC have poor diagnostic performance. [12] Surgical treatment is the mainstay of treatment for phyllodes. Wide local excision with at least 1 cm tumor-free margins should be kept. Since excision with required margins is impossible in giant phyllodes, mastectomy should be done for larger tumors and also in cases of recurrent tumors, especially of malignant histology. [13] Mastectomy may also be required for tumors between 5 and 10 cm in diameter depending on the size and location of phyllodes. Trucut biopsy is considered the most valuable prediagnostic test for phyllodes tumor. It has greater accuracy than other methods in diagnosing phyllodes but has limited clinical significance. Accurate diagnostic rates of core needle biopsy are variable, but most studies show below 50%. [13] Komenaka et al. found sensitivity to be 99% with negative predictive value and positive predictive value of 93% and 83%, respectively, while the accuracy rates of 76%. [14] Ward et al. reported accurate diagnostic rate of core needle biopsy to be 63%. [15] In our study, sensitivity of trucut in diagnosing benign phyllodes was 100% and specificity was 46.15% while sensitivity of trucut in diagnosing malignant phyllodes was 66.6% and specificity was 100%. Jacob et al. found that four stromal features (cellularity, nuclear atypia, mitoses, and amount of stroma) in core needle biopsy specimen differed significantly between cases that were fibroadenoma or phyllodes at excision. [16, 17] Lymph node dissection is not recommended as nodal metastasis is rare. Bhargav et al. stated that regardless of the histological grade, wide local excision should be the first choice of treatment and all patients with recurrence should undergo mastectomy. [18] Ben Hassouna et al. proposed mastectomy as the preferred surgical approach for malignant phyllodes. [19] Chest wall invasion appears to be an uncommon event with phyllodes tumors. [20] In our series, wide local excision was done in nine patients, mastectomy was performed in seven while MRM was performed in four cases. The role of adjuvant radiotherapy and chemotherapy in phyllodes is uncertain.
In the present study, the WHO 2012 classification was used in evaluating the surgical specimens. [21] Parameters used were stromal cellularity, atypia, mitosis per 10 HPF, stromal overgrowth, and tumor margins. These histologic parameters were evaluated as follows in surgical specimens. [22] Stromal cellularity was evaluated in most cellular areas and graded as mild, moderate, and severe. Stromal atypia was also graded as mild, moderate, and severe depending on size, pleomorphism, and presence of nucleoli. Mitotic activity was evaluated in more cellular areas and quantified per 10 HPF. Stromal overgrowth was defined by stromal proliferation without accompanying epithelial elements in at least one low-power field. Tumor margins were graded as well defined, focally infiltrative, and infiltrative. The term infiltrative was used when projection of tumor stroma was seen into the peritumoral stroma or adipose tissue. In summary, trucut is a good prediagnostic method but its accuracy rates become limited. Features of benign phyllodes can easily overlap with those of cellular fibroadenoma. Furthermore, features of benign and borderline phyllodes are quite overlapping; in these cases, mitosis appears to be the most important parameter. Sarcoma breast and metaplastic carcinoma can also be close differential diagnosis of malignant phyllodes if epithelial components are absent. Hence, due to varied morphological features of phyllodes, its sole diagnosis should not be based on trucut. Excision biopsy provides the final confirmation of the diagnosis.
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